Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    2%
    Check dated 2025-05-07T19:23:01.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    1%
    Check dated 2025-04-30T13:57:59.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    2%
    Check dated 2025-04-23T08:35:40.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has removed detailed information about a Phase 1 clinical trial for LAVA-051, including key inclusion and exclusion criteria for participants, while adding a new revision number.
    Difference
    22%
    Check dated 2025-04-16T02:05:58.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has been changed from March 25, 2025, to January 27, 2025.
    Difference
    2%
    Check dated 2025-04-08T23:40:05.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has removed references to Acute Graft Versus Host Disease and added information about Multiple Myeloma.
    Difference
    0.3%
    Check dated 2025-04-01T18:34:21.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.